Edwards Lifesciences - EW Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $92.42
Forecasted Upside: 31.69%
Number of Analysts: 18
Breakdown:
1 Sell Ratings
9 Hold Ratings
8 Buy Ratings
0 Strong Buy Ratings

^$70.18 As of 09/21/2023 01:00 AM ET

▼ -1.77 (-2.46%)

1 month | 3 months | 12 months

Get New Edwards Lifesciences Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for EW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EW

^$92.42

▲ +31.69% Upside Potential

This price target is based on 18 analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is $92.42, with a high forecast of $110.00 and a low forecast of $66.00. The average price target represents a 31.69% upside from the last price of $70.18.

Current Consensus is Hold

The current consensus among 18 polled investment analysts is to hold stock in Edwards Lifesciences. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

3/30/2022

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

6/28/2022

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

9/26/2022

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

12/25/2022

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

3/25/2023

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

6/23/2023

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

8/22/2023

0 strong buy ratings
8 buy ratings
9 hold ratings
1 sell ratings

Ratings as of

9/21/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
9/8/2023	Piper Sandler	Lower Target	Neutral ➝ Neutral	$88.00 ➝ $83.00	Low
8/17/2023	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$96.00	Low
8/1/2023	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$96.00	Low
7/27/2023	Piper Sandler	Boost Target		$83.00 ➝ $88.00	Low
7/25/2023	Jefferies Financial Group	Boost Target	Buy	$103.00 ➝ $107.00	Low
7/19/2023	Truist Financial	Boost Target		$101.00 ➝ $105.00	Low
7/18/2023	Robert W. Baird	Initiated Coverage	Outperform	$107.00	Low
7/17/2023	Mizuho	Boost Target		$95.00 ➝ $102.00	Low
7/14/2023	Morgan Stanley	Reiterated Rating	Overweight ➝ Overweight	$102.00	Low
7/10/2023	Citigroup	Boost Target		$101.00 ➝ $110.00	Low
6/27/2023	58.com	Reiterated Rating	Reiterates		Low
5/30/2023	Morgan Stanley	Initiated Coverage	Overweight	$102.00	Low
5/18/2023	Truist Financial	Boost Target		$97.00 ➝ $101.00	Low
4/28/2023	Barclays	Boost Target		$94.00 ➝ $102.00	Low
4/27/2023	Wells Fargo & Company	Boost Target		$78.00 ➝ $90.00	Low
4/27/2023	Piper Sandler	Boost Target		$80.00 ➝ $83.00	Low
4/27/2023	Truist Financial	Boost Target		$93.00 ➝ $97.00	Low
4/25/2023	Mizuho	Boost Target		$85.00 ➝ $95.00	Low
4/24/2023	Stifel Nicolaus	Boost Target		$75.00 ➝ $87.00	Low
4/17/2023	Truist Financial	Boost Target	Buy	$86.00 ➝ $93.00	Low
4/3/2023	Citigroup	Boost Target	Buy	$92.00 ➝ $97.00	Low
3/28/2023	UBS Group	Initiated Coverage	Neutral	$84.00	Low
3/8/2023	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$97.00 ➝ $78.00	N/A
2/6/2023	Raymond James	Downgrade	Outperform ➝ Market Perform		Low
2/1/2023	Canaccord Genuity Group	Boost Target	Hold	$68.00 ➝ $76.00	Low
2/1/2023	Truist Financial	Boost Target	Buy	$85.00 ➝ $86.00	Low
1/31/2023	Sanford C. Bernstein	Downgrade	Outperform ➝ Underperform	$95.00 ➝ $66.00	Low
1/30/2023	Piper Sandler	Downgrade	Overweight ➝ Neutral	$95.00 ➝ $80.00	Low
1/6/2023	Morgan Stanley	Boost Target	Overweight	$92.00 ➝ $95.00	Low
12/13/2022	Raymond James	Lower Target	Outperform	$85.00 ➝ $83.00	Low
12/12/2022	Canaccord Genuity Group	Lower Target	Hold ➝ Hold	$78.00 ➝ $73.00	Low
12/12/2022	Citigroup	Lower Target	Buy	$99.00 ➝ $92.00	Low
12/9/2022	Morgan Stanley	Lower Target		$98.00 ➝ $92.00	Low
12/7/2022	Mizuho	Lower Target	Buy	$100.00 ➝ $85.00	Low
12/5/2022	Stifel Nicolaus	Downgrade	Buy ➝ Hold	$95.00 ➝ $75.00	Low
12/1/2022	Wolfe Research	Downgrade	Outperform ➝ Market Perform		Low
11/28/2022	Royal Bank of Canada	Lower Target	Outperform	$118.00 ➝ $105.00	Low
11/3/2022	The Goldman Sachs Group	Lower Target	Neutral	$97.00 ➝ $73.00	Low
10/31/2022	Raymond James	Lower Target	Outperform	$120.00 ➝ $85.00	Low
10/28/2022	Royal Bank of Canada	Lower Target	Outperform	$128.00 ➝ $118.00	Low
10/28/2022	Morgan Stanley	Lower Target	Overweight	$108.00 ➝ $98.00	Low
10/28/2022	Wells Fargo & Company	Lower Target	Overweight	$121.00 ➝ $93.00	Low
10/28/2022	Truist Financial	Lower Target	Buy	$112.00 ➝ $95.00	Low
10/28/2022	Cowen	Lower Target		$125.00 ➝ $100.00	Low
10/28/2022	Cowen	Lower Target		$125.00 ➝ $100.00	Low
10/28/2022	Deutsche Bank Aktiengesellschaft	Lower Target		$113.00 ➝ $83.00	Low
10/28/2022	Citigroup	Lower Target	Buy	$107.00 ➝ $99.00	Low
10/28/2022	Oppenheimer	Downgrade	Outperform ➝ Market Perform		Low
10/28/2022	Piper Sandler	Lower Target	Overweight	$120.00 ➝ $95.00	N/A
10/26/2022	Mizuho	Initiated Coverage	Buy	$100.00	Low
10/17/2022	Barclays	Initiated Coverage	Overweight	$96.00	Low
10/14/2022	Canaccord Genuity Group	Lower Target		$106.00 ➝ $91.00	Low
10/12/2022	Jefferies Financial Group	Initiated Coverage	Buy	$110.00	Low
10/11/2022	Morgan Stanley	Lower Target	Overweight	$119.00 ➝ $108.00	Low
10/5/2022	Citigroup	Lower Target		$118.00 ➝ $107.00	Low
9/22/2022	Truist Financial	Lower Target	Buy	$117.00 ➝ $112.00	Low
7/29/2022	Canaccord Genuity Group	Downgrade	Buy ➝ Hold	$115.00 ➝ $106.00	Low
7/20/2022	Truist Financial	Lower Target	Buy	$140.00 ➝ $120.00	Low
7/18/2022	Stifel Nicolaus	Lower Target		$128.00 ➝ $115.00	Low
7/15/2022	Morgan Stanley	Lower Target	Overweight	$136.00 ➝ $119.00	Low
7/11/2022	Cowen	Lower Target		$140.00 ➝ $125.00	N/A
7/11/2022	Cowen	Lower Target		$140.00 ➝ $125.00	N/A
5/17/2022	Citigroup	Lower Target	Buy	$134.00 ➝ $115.00	N/A
4/27/2022	Canaccord Genuity Group	Lower Target		$152.00 ➝ $137.00	High
4/27/2022	Citigroup	Lower Target		$138.00 ➝ $134.00	High
4/26/2022	William Blair	Reiterated Rating	Outperform		Low
4/12/2022	Truist Financial	Initiated Coverage	Buy	$145.00	Low
4/5/2022	Wolfe Research	Initiated Coverage	Outperform	$134.00	Low
3/16/2022	Sanford C. Bernstein	Upgrade	Market Perform ➝ Outperform	$132.00 ➝ $135.00	Low
3/1/2022	Bank of America	Initiated Coverage	Neutral ➝ Neutral		Low
2/2/2022	UBS Group	Upgrade	Neutral ➝ Buy	$121.00 ➝ $126.00	Low
1/27/2022	Evercore ISI	Lower Target	Outperform	$130.00 ➝ $122.00	High
1/27/2022	UBS Group	Lower Target	Neutral	$125.00 ➝ $121.00	High
1/27/2022	Citigroup	Lower Target	Buy	$142.00 ➝ $138.00	High
1/27/2022	Stifel Nicolaus	Lower Target	Buy	$132.00 ➝ $120.00	High
1/27/2022	Morgan Stanley	Lower Target	Overweight	$148.00 ➝ $136.00	High
1/27/2022	Raymond James	Lower Target	Outperform	$134.00 ➝ $126.00	High
1/27/2022	Piper Sandler	Lower Target		$133.00 ➝ $125.00	High
1/21/2022	SVB Leerink	Lower Target	Outperform	$135.00 ➝ $132.00	High
1/7/2022	Credit Suisse Group	Boost Target	Outperform	$131.00 ➝ $144.00	Low
1/7/2022	Morgan Stanley	Boost Target	Overweight	$144.00 ➝ $148.00	Medium
12/17/2021	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$114.00 ➝ $140.00	High
12/15/2021	Citigroup	Upgrade	Neutral ➝ Buy	$120.00 ➝ $142.00	Medium
12/10/2021	Raymond James	Boost Target	Outperform ➝ Outperform	$127.00 ➝ $134.00	Low
12/9/2021	Royal Bank of Canada	Initiated Coverage	Outperform	$142.00	Low
12/9/2021	Morgan Stanley	Boost Target	Overweight	$135.00 ➝ $144.00	Medium
12/9/2021	SVB Leerink	Boost Target	Outperform	$130.00 ➝ $135.00	Low
12/8/2021	Piper Sandler	Boost Target	Overweight ➝ Overweight	$123.00 ➝ $133.00	Low
12/6/2021	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$126.00	High
10/29/2021	Jefferies Financial Group	Boost Target	Buy	$130.00 ➝ $135.00	High
10/28/2021	Credit Suisse Group	Boost Target	Outperform	$126.00 ➝ $130.00	High
10/28/2021	Wells Fargo & Company	Boost Target	Equal Weight	$115.00 ➝ $126.00	High
10/28/2021	Raymond James	Boost Target	Outperform	$122.00 ➝ $127.00	High
10/28/2021	Citigroup	Boost Target	Neutral	$113.00 ➝ $120.00	High
8/3/2021	The Goldman Sachs Group	Boost Target	Neutral	$93.00 ➝ $105.00	Low
8/2/2021	Raymond James	Boost Target	Outperform	$101.00 ➝ $122.00	Low
7/30/2021	Credit Suisse Group	Boost Target	Outperform	$112.00 ➝ $126.00	High
7/30/2021	Morgan Stanley	Boost Target	Overweight	$108.00 ➝ $135.00	High
7/30/2021	Oppenheimer	Boost Target	Outperform	$97.00 ➝ $120.00	High
7/30/2021	Stifel Nicolaus	Boost Target	Buy	$103.00 ➝ $120.00	High
7/30/2021	UBS Group	Boost Target	Neutral	$98.00 ➝ $115.00	High
7/30/2021	SVB Leerink	Boost Target	Outperform	$125.00 ➝ $130.00	Medium
7/30/2021	Jefferies Financial Group	Boost Target	Buy	$110.00 ➝ $130.00	High
7/30/2021	Wells Fargo & Company	Boost Target	Equal Weight	$93.00 ➝ $115.00	High
7/30/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$84.00 ➝ $113.00	High
7/27/2021	Piper Sandler	Boost Target	Overweight	$105.00 ➝ $120.00	Low
7/23/2021	Cowen	Boost Target	Outperform	$100.00 ➝ $125.00	Low
7/20/2021	SVB Leerink	Boost Target	Outperform	$106.00 ➝ $125.00	Low
5/24/2021	Barclays	Initiated Coverage	Overweight	$110.00	Low
4/21/2021	Morgan Stanley	Boost Target	Overweight	$99.00 ➝ $108.00	High
4/21/2021	Raymond James	Boost Target	Outperform	$96.00 ➝ $101.00	High
4/21/2021	Wells Fargo & Company	Boost Target	Equal Weight	$87.00 ➝ $93.00	High
4/21/2021	Piper Sandler	Boost Target	Overweight	$97.00 ➝ $105.00	High
4/15/2021	Atlantic Securities	Initiated Coverage	Neutral	$85.00	Low
4/5/2021	Evercore ISI	Upgrade	In-Line ➝ Outperform		Medium
12/16/2020	Smith Barney Citigroup	Downgrade	Buy ➝ Neutral		Low
12/14/2020	Morgan Stanley	Boost Target	Overweight	$88.00 ➝ $99.00	Medium
12/11/2020	Raymond James	Boost Target	Outperform	$90.00 ➝ $96.00	Low
12/11/2020	Piper Sandler	Boost Target	Overweight	$93.00 ➝ $98.00	High
12/11/2020	SVB Leerink	Boost Target	Outperform	$100.00 ➝ $106.00	High
12/7/2020	Credit Suisse Group	Boost Target		$97.00 ➝ $111.00	Medium
11/18/2020	Wells Fargo & Company	Boost Target	Equal Weight	$84.00 ➝ $87.00	Low
10/27/2020	Jefferies Financial Group	Boost Target	Buy	$95.00 ➝ $105.00	Medium
10/22/2020	Credit Suisse Group	Boost Target	Outperform	$92.00 ➝ $97.00	High
10/22/2020	Raymond James	Boost Target	Outperform	$88.00 ➝ $90.00	High
10/19/2020	Cowen	Boost Target	Outperform	$85.00 ➝ $100.00	Medium
10/14/2020	Piper Sandler	Boost Target	Overweight	$91.00 ➝ $93.00	Low
10/12/2020	SVB Leerink	Boost Target	Outperform	$95.00 ➝ $100.00	Low
9/11/2020	Wolfe Research	Initiated Coverage	Underperform		Low
7/24/2020	Stifel Nicolaus	Boost Target	Buy	$85.00 ➝ $90.00	Low
7/24/2020	Jefferies Financial Group	Boost Target	Buy	$87.00 ➝ $95.00	Low
7/24/2020	Credit Suisse Group	Boost Target	Outperform	$88.00 ➝ $92.00	High
7/24/2020	Morgan Stanley	Boost Target	Overweight	$83.00 ➝ $88.00	High
7/24/2020	SVB Leerink	Boost Target	Outperform	$90.00 ➝ $95.00	High
7/24/2020	Raymond James	Boost Target	Outperform	$83.00 ➝ $88.00	High
7/24/2020	Piper Sandler	Boost Target	Positive ➝ Overweight	$88.00 ➝ $91.00	High
7/13/2020	Oppenheimer	Initiated Coverage	Buy	$93.00	High
6/29/2020	Morgan Stanley	Lower Target	Overweight	$83.33 ➝ $83.00	Low
6/2/2020	Credit Suisse Group	Lower Target	Outperform	$88.00	High
6/1/2020	Morgan Stanley	Lower Target	Overweight	$83.33 ➝ $83.00	N/A
4/28/2020	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$83.33 ➝ $76.67	High
4/27/2020	Barclays	Reiterated Rating	Underweight	$55.00 ➝ $51.67	High
4/24/2020	Cfra	Boost Target	Buy	$67.00 ➝ $77.00	Low
4/24/2020	Raymond James	Boost Target	Outperform	$76.67 ➝ $83.33	Low
4/24/2020	Stifel Nicolaus	Boost Target	Buy	$76.67 ➝ $85.00	Low
4/24/2020	Piper Sandler	Lower Target	Overweight	$90.00 ➝ $88.33	Low
4/24/2020	Morgan Stanley	Boost Target	Overweight	$80.33 ➝ $83.33	High
4/24/2020	Credit Suisse Group	Boost Target	Outperform	$86.67 ➝ $87.33	High
4/24/2020	Wells Fargo & Company	Boost Target	Overweight	$71.67 ➝ $83.33	High
4/24/2020	Citigroup	Boost Target	Buy	$80.00 ➝ $85.00	High
4/23/2020	BTIG Research	Reiterated Rating	Hold		High
4/22/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$81.67 ➝ $75.00	Low
4/20/2020	Cowen	Lower Target	Top Pick ➝ Outperform	$91.67 ➝ $83.33	Medium
4/19/2020	SVB Leerink	Downgrade	Outperform ➝ Market Perform		Medium
4/17/2020	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$90.00	High
4/9/2020	Raymond James	Lower Target	Outperform	$87.67 ➝ $76.67	High
4/6/2020	Wells Fargo & Company	Lower Target	Overweight	$90.67 ➝ $71.67	Low
3/27/2020	Morgan Stanley	Lower Target	Overweight	$90.00 ➝ $80.33	Low
3/27/2020	Citigroup	Lower Target	Buy	$84.00 ➝ $80.00	Low
3/13/2020	Cfra	Upgrade	Sell ➝ Hold	$69.00 ➝ $67.00	High
3/6/2020	Credit Suisse Group	Lower Target	Outperform	$92.67 ➝ $89.00	Low
3/4/2020	Citigroup	Initiated Coverage	Buy	$84.00	Low
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$84.33	Low
2/6/2020	BTIG Research	Initiated Coverage	Hold		Medium
1/31/2020	Cfra	Boost Target	Sell	$68.33 ➝ $69.00	High
1/31/2020	Stifel Nicolaus	Boost Target	Buy	$91.67 ➝ $93.33	High
1/31/2020	Wells Fargo & Company	Boost Target	Overweight	$90.00 ➝ $90.67	High
1/31/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$78.67 ➝ $81.67	High
1/31/2020	Credit Suisse Group	Boost Target	Outperform	$91.67 ➝ $92.67	High
1/31/2020	Piper Sandler	Boost Target	Overweight	$87.33 ➝ $90.00	High
1/31/2020	UBS Group	Boost Target	Neutral	$85.00 ➝ $86.67	High
1/9/2020	Oppenheimer	Upgrade	Market Perform ➝ Buy	$93.33	Medium
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$54.67	Low
12/17/2019	Cowen	Reiterated Rating	Buy	$91.67	Medium
12/9/2019	Piper Jaffray Companies	Boost Target	Overweight	$85.00 ➝ $87.33	High
12/6/2019	UBS Group	Boost Target	Neutral	$83.33 ➝ $85.00	High
12/6/2019	Wells Fargo & Company	Boost Target	Outperform	$87.33 ➝ $90.00	High
12/6/2019	Credit Suisse Group	Boost Target	Outperform	$89.67 ➝ $91.67	High
12/6/2019	Morgan Stanley	Boost Target	Overweight	$82.67 ➝ $90.00	High
12/6/2019	Raymond James	Boost Target	Outperform	$85.00 ➝ $87.67	High
12/3/2019	Jefferies Financial Group	Boost Target	Buy	$85.00 ➝ $95.00	Low
10/24/2019	Raymond James	Boost Target	Outperform	$83.33 ➝ $85.00	High
10/24/2019	Cowen	Boost Target	Outperform ➝ Positive	$83.33 ➝ $88.33	High
10/24/2019	Wells Fargo & Company	Boost Target	Outperform	$83.33 ➝ $87.33	High
10/24/2019	Piper Jaffray Companies	Boost Target	Overweight	$80.00 ➝ $85.00	High
10/22/2019	Royal Bank of Canada	Boost Target	Buy ➝ Outperform	$72.33 ➝ $83.33	Medium
10/16/2019	UBS Group	Boost Target	Neutral	$68.33 ➝ $76.67	Low
10/14/2019	Raymond James	Boost Target	Outperform	$77.33 ➝ $83.33	Low
10/14/2019	Credit Suisse Group	Boost Target	Positive ➝ Outperform	$75.33 ➝ $87.00	Low
9/23/2019	Piper Jaffray Companies	Initiated Coverage	Overweight	$80.00 ➝ $80.00	Low
9/6/2019	Wells Fargo & Company	Boost Target	Outperform	$73.33 ➝ $83.33	Low
7/26/2019	Citigroup	Set Target	Sell	$53.00	Low
7/25/2019	BTIG Research	Reiterated Rating	Hold		Low
7/24/2019	BMO Capital Markets	Boost Target	Outperform	$68.00 ➝ $74.67	Low
7/24/2019	JPMorgan Chase & Co.	Boost Target	Neutral	$63.33 ➝ $75.00	Low
7/24/2019	Bank of America	Reiterated Rating	Buy ➝ Buy	$71.67 ➝ $75.00	Low
7/24/2019	Wells Fargo & Company	Boost Target	Outperform	$69.00 ➝ $73.33	High
7/24/2019	Morgan Stanley	Boost Target	Overweight	$70.00 ➝ $76.00	High
7/24/2019	Raymond James	Boost Target	Outperform	$66.67 ➝ $77.33	High
7/24/2019	Barclays	Boost Target	Underweight	$53.33 ➝ $58.33	High
7/24/2019	Credit Suisse Group	Boost Target	Outperform	$73.67 ➝ $75.33	High
7/24/2019	Jefferies Financial Group	Boost Target	Buy	$70.00 ➝ $81.67	High
7/16/2019	Morgan Stanley	Boost Target	Overweight	$65.67 ➝ $70.00	Medium
4/24/2019	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$63.33 ➝ $66.67	Low
4/24/2019	Deutsche Bank Aktiengesellschaft	Boost Target	Hold ➝ Hold	$54.67 ➝ $61.33	Low
4/24/2019	Jefferies Financial Group	Boost Target	Buy	$65.00 ➝ $70.00	Low
4/24/2019	Raymond James	Lower Target	Outperform ➝ Outperform	$70.00 ➝ $66.67	Low
4/24/2019	BTIG Research	Reiterated Rating	Hold		Low
4/15/2019	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$63.00 ➝ $73.67	Low
3/27/2019	JPMorgan Chase & Co.	Boost Target	Neutral	$58.33 ➝ $63.33	Low
3/25/2019	Barclays	Boost Target	Underweight	$50.00 ➝ $53.33	Low
3/22/2019	BMO Capital Markets	Boost Target	Outperform	$68.00	Low
3/18/2019	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$60.00 ➝ $65.67	High
3/18/2019	Wells Fargo & Company	Boost Target	Outperform	$62.67 ➝ $67.33	High
3/18/2019	Bank of America	Boost Target	Buy ➝ Buy	$63.33 ➝ $71.67	Medium
3/12/2019	UBS Group	Boost Target	Neutral ➝ Neutral	$58.33 ➝ $60.00	Medium
2/25/2019	Citigroup	Boost Target	Sell ➝ Sell	$39.67 ➝ $43.33	Medium
2/4/2019	Cowen	Reiterated Rating	Buy		Medium
2/3/2019	Stifel Nicolaus	Reiterated Rating	Buy	$63.33	Medium
1/18/2019	Bank of America	Upgrade	Neutral ➝ Buy	$60.00 ➝ $63.33	High
1/2/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold ➝ Hold	$54.67	High
1/2/2019	Citigroup	Boost Target	Sell ➝ Sell	$39.33 ➝ $39.67	Low
12/17/2018	Credit Suisse Group	Initiated Coverage	Outperform	$62.67	Low
12/10/2018	Cowen	Set Target	Buy	$63.33	Low
12/7/2018	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$52.33 ➝ $60.00	Medium
12/6/2018	Stifel Nicolaus	Reiterated Rating	Positive		High
12/6/2018	Raymond James	Boost Target	Outperform ➝ Outperform	$53.33 ➝ $58.33	High
12/6/2018	Royal Bank of Canada	Boost Target	Outperform	$58.33	High
12/6/2018	Jefferies Financial Group	Boost Target	Positive ➝ Buy	$56.00 ➝ $60.00	High
11/30/2018	Cowen	Set Target	Buy	$63.33	Low
11/27/2018	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$55.00 ➝ $55.00	High
10/29/2018	Citigroup	Lower Target	Sell ➝ Sell	$40.33 ➝ $39.33	High
10/24/2018	Barclays	Set Target	Sell	$47.67	High
10/15/2018	Barclays	Initiated Coverage	Underweight ➝ Underweight	$47.67	High
10/11/2018	Morgan Stanley	Boost Target	Overweight	$50.00 ➝ $52.33	Medium
10/11/2018	Northland Securities	Reiterated Rating	Hold	$40.00	Medium
10/2/2018	Bank of America	Downgrade	Buy ➝ Neutral		Medium
10/2/2018	Guggenheim	Downgrade	Buy ➝ Neutral		High
9/28/2018	SunTrust Banks	Boost Target	Buy	$66.67	Medium

(Data available from 9/21/2018 forward)

News Sentiment Rating

1.01 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

10 very positive mentions
21 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

2/23/2023

13 very positive mentions
10 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

3/25/2023

25 very positive mentions
14 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

4/24/2023

26 very positive mentions
39 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

5/24/2023

15 very positive mentions
11 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

6/23/2023

23 very positive mentions
15 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

7/23/2023

16 very positive mentions
25 positive mentions
2 negative mentions
3 very negative mentions

Mentions as of

8/22/2023

25 very positive mentions
11 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

9/21/2023

Current Sentiment

Recent Stories by Sentiment

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $70.18

$70.04

$71.89

50 Day Range

MA: $80.19

$71.95

$93.38

52 Week Range

Now: $70.18

$67.13

$94.87

Volume

3,008,634 shs

Average Volume

3,169,766 shs

Market Capitalization

$42.66 billion

P/E Ratio

31.05

Dividend Yield

N/A

Beta

1.03

Frequently Asked Questions

What sell-side analysts currently cover shares of Edwards Lifesciences?: The following equities research analysts have issued reports on Edwards Lifesciences in the last twelve months: 58.com Inc., Barclays PLC, Canaccord Genuity Group Inc., Citigroup Inc., Cowen Inc, Cowen Inc., Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for EW.
What is the current price target for Edwards Lifesciences?: 19 Wall Street analysts have set twelve-month price targets for Edwards Lifesciences in the last year. Their average twelve-month price target is $92.42, suggesting a possible upside of 31.7%. Citigroup Inc. has the highest price target set, predicting EW will reach $110.00 in the next twelve months. Sanford C. Bernstein has the lowest price target set, forecasting a price of $66.00 for Edwards Lifesciences in the next year.
View the latest price targets for EW.
What is the current consensus analyst rating for Edwards Lifesciences?: Edwards Lifesciences currently has 1 sell rating, 9 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in EW, but not buy more shares or sell existing shares.
View the latest ratings for EW.
What other companies compete with Edwards Lifesciences?: Other companies that are similar to Edwards Lifesciences include STERIS, Intuitive Surgical, Zimmer Biomet, Align Technology and Smith & Nephew. Learn More about companies similar to Edwards Lifesciences.
How do I contact Edwards Lifesciences' investor relations team?: Edwards Lifesciences' physical mailing address is ONE EDWARDS WAY, IRVINE CA, 92614. The medical research company's listed phone number is (949) 250-2500 and its investor relations email address is investor_relation[email protected]. The official website for Edwards Lifesciences is www.edwards.com. Learn More about contacing Edwards Lifesciences investor relations.

Edwards Lifesciences - EW Stock Price Target and Predictions

Analyst Price Target for EW

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

1.01 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Edwards Lifesciences?

What is the current price target for Edwards Lifesciences?

What is the current consensus analyst rating for Edwards Lifesciences?

What other companies compete with Edwards Lifesciences?

How do I contact Edwards Lifesciences' investor relations team?